EC Number | Application | Comment | Organism |
---|---|---|---|
1.14.18.1 | drug development | acetazolamide is a good candidate for the inhibition of melanin biosynthesis. and might be used as a lead for developing the drugs for treatment of hyperpigmentary disorders and skin whitening | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.14.18.1 | 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide | acetazolamide or ACZ, in vitro, in vivo studies, and in silico docking studies. Inhibition kinetics, noncompetitive inhibition. Molecular dynamics simulations, overview | Agaricus bisporus | |
1.14.18.1 | 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide | acetazolamide or ACZ, in vitro, in vivo studies, and in silico docking studies, His244, Asn260 and His85 are the major interacting residues in the binding site of the protein. Inhibition kinetics, acetazolamide is a noncompetitive inhibitor without cytotoxic effect. Molecular dynamics simulations, overview | Danio rerio | |
1.14.18.1 | 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide | acetazolamideor ACZ, in vitro, in vivo, and in silico studies, inhibition kinetics. Acetazolamide is a a noncompetitive inhibitor without cytotoxic effect showing inhibition of tyrosinase expression in L-DOPA-induced melanoma. Molecular dynamics simulations, overview | Homo sapiens | |
1.14.18.1 | arbutin | - |
Danio rerio | |
1.14.18.1 | arbutin | - |
Homo sapiens | |
1.14.18.1 | hydroquinone | - |
Danio rerio | |
1.14.18.1 | hydroquinone | - |
Homo sapiens | |
1.14.18.1 | kojic acid | - |
Agaricus bisporus | |
1.14.18.1 | kojic acid | - |
Danio rerio | |
1.14.18.1 | kojic acid | - |
Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.14.18.1 | 0.172 | - |
L-Dopa | pH 6.8, 25°C | Agaricus bisporus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
1.14.18.1 | membrane | membrane-bound | Homo sapiens | 16020 | - |
1.14.18.1 | membrane | membrane-bound | Agaricus bisporus | 16020 | - |
1.14.18.1 | membrane | membrane-bound | Danio rerio | 16020 | - |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
1.14.18.1 | Cu2+ | a copper-containing enzyme | Homo sapiens | |
1.14.18.1 | Cu2+ | a copper-containing enzyme | Agaricus bisporus | |
1.14.18.1 | Cu2+ | a copper-containing enzyme | Danio rerio |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.18.1 | 2 L-dopa + O2 | Homo sapiens | - |
2 dopaquinone + 2 H2O | - |
? | |
1.14.18.1 | 2 L-dopa + O2 | Agaricus bisporus | - |
2 dopaquinone + 2 H2O | - |
? | |
1.14.18.1 | 2 L-dopa + O2 | Danio rerio | - |
2 dopaquinone + 2 H2O | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.14.18.1 | Agaricus bisporus | - |
- |
- |
1.14.18.1 | Danio rerio | - |
- |
- |
1.14.18.1 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.14.18.1 | A-375 cell | - |
Homo sapiens | - |
1.14.18.1 | commercial preparation | - |
Agaricus bisporus | - |
1.14.18.1 | melanoma cell | - |
Homo sapiens | - |
1.14.18.1 | skin | - |
Homo sapiens | - |
1.14.18.1 | skin | - |
Danio rerio | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.18.1 | 2 L-dopa + O2 | - |
Homo sapiens | 2 dopaquinone + 2 H2O | - |
? | |
1.14.18.1 | 2 L-dopa + O2 | - |
Agaricus bisporus | 2 dopaquinone + 2 H2O | - |
? | |
1.14.18.1 | 2 L-dopa + O2 | - |
Danio rerio | 2 dopaquinone + 2 H2O | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.14.18.1 | mushroom tyrosinase | - |
Agaricus bisporus |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
1.14.18.1 | 25 | - |
assay at | Agaricus bisporus |
1.14.18.1 | 25 | - |
in vitro assay at | Homo sapiens |
1.14.18.1 | 37 | - |
in vivo assay at | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
1.14.18.1 | 6.8 | - |
assay at | Homo sapiens |
1.14.18.1 | 6.8 | - |
assay at | Agaricus bisporus |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.14.18.1 | 0.007895 | - |
2-acetylamino-1,3,4-thiadiazole-5-sulfonamide | pH 6.8, 25°C | Homo sapiens | |
1.14.18.1 | 0.01261 | - |
2-acetylamino-1,3,4-thiadiazole-5-sulfonamide | pH 6.8, 25°C | Agaricus bisporus | |
1.14.18.1 | 0.01684 | - |
kojic acid | pH 6.8, 25°C | Homo sapiens |
EC Number | General Information | Comment | Organism |
---|---|---|---|
1.14.18.1 | malfunction | after 72 h of treatment with inhibitors acetazolamide and kojic acid, acetazolamide at 0.04 mM significantly decreases the embryos pigmentation to 40.8% of untreated embryos, while kojic acid at 0.04 mM decreases only 25.0% of pigmentation. Phenotype, overview | Danio rerio |
1.14.18.1 | malfunction | enzyme inhibition reduces melanogenesis | Homo sapiens |
1.14.18.1 | additional information | molecular docking and molecular dynamic simulation | Homo sapiens |
1.14.18.1 | additional information | molecular docking and molecular dynamic simulation | Danio rerio |